$VYX

NCR Voyix (VYX) Is Attractively Priced Despite Fast-paced Momentum

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, NCR Voyix (VYX) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Original reporting
Zacks Commentary · Zacks Equity Research
Published May 29, 2025, 12:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 30, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NCR Voyix (VYX) Is Attractively Priced Despite Fast-paced Momentum — source image
Decision brief

The 30-second read

$VYXBullishMed
01

Why it matters

The stock's momentum suggests investor confidence, but valuation metrics should be monitored to avoid overextension.

02

Market read

The news indicates a potentially actionable opportunity for traders focusing on momentum stocks within the technology sector.

03

What to watch

Market volatility and broader economic uncertainties could impact stock performance despite positive momentum.

Timing: short-term (next 1-3 months)

Background

NCR Voyix (VYX) has recently demonstrated strong price gains driven by favorable earnings reports and sector-wide optimism.

Company-level read

Ticker impact

$VYXBullishMedium confidence
Context

The article highlights NCR Voyix (VYX) as a stock with recent strong momentum and attractive valuation, suggesting potential trading opportunities.

Expected impact

Moderate upward price movement expected in the short to medium term.

Evidence & confidence

The stock's momentum coupled with attractive valuation suggests a favorable outlook; however, limited technical data and market volatility introduce some uncertainty.

Market effects

Potential positive impact on the technology and financial sectors if VYX's momentum continues.

Limited regional impact; primarily relevant to domestic markets where VYX is traded.

Minimal global market influence due to stock-specific nature.

Counterpoint

The stock's recent momentum may be a short-term anomaly; fundamentals could deteriorate, leading to a reversal.

Key entities

  • NCR Voyix

    A technology company with recent positive earnings and market momentum.

Related articles

$VYXMed

NCR Voyix Q2 Earnings Call Highlights

NCR Voyix (NYSE:VYX) reported Q2 progress on enterprise platform transformations, including a remote Voyix POS installation for a large European grocery retailer completed in about half the usual time. Retail signed 40+ customers; retail revenue fell 20% to $365M due to hardware transition, but adjusted EBITDA rose 20% to $97M. Restaurant revenue fell 23% to $158M. Non-GAAP EPS was $0.17. Full-year 2026 outlook maintained: revenue $2.188B-$2.303B, adj EBITDA $432M-$447M, EPS $0.89-$0.92.

$VYXMedAI 8/10

NCR Voyix: Q2 Earnings Snapshot

NCR Voyix (VYX) reported Q2 earnings of $2 million and a net loss of 1 cent per share. Adjusted earnings were 17 cents per share, and revenue was $523 million. The company expects full-year earnings of 89 to 92 cents per share and revenue of $2.19 billion to $2.3 billion.

$VYXMed

NCR Voyix Corp (VYX): Completion of Acquisition or Disposition of Assets

NCR Voyix Corp (VYX) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.1 2 exhibit991-q22026earningsr.htm EX-99.1 Document NEWS RELEASE NCR Voyix Reports Second Quarter 2026 Results ATLANTA, August 5, 2026 - NCR Voyix Corporation (NYSE: VYX) (“NCR Voyix” or the “Company”), a platform-powered leader in unified commerce for shopping and dining,

$MDTMed

Jury Orders Medtronic to Pay $88 Million After Finding Surgeons Were Not Adequately Warned About a Hernia Mesh

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.